Gout

Febuxostat was FDA-approved in 2009 to treat gout in adults.

The statement is intended to serve as a discussion guide for the risk factors, diagnosis, treatment and prevention of the disease.

Nonsteroidal anti-inflammatory drugs should be used as the first line treatment for acute gout.

The FDA has approved Duzallo (lesinurad and allopurinol; Ironwood Pharmaceuticals, Inc) for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid (sUA) levels with a medically appropriate daily dose of allopurinol alone.

Febuxostat (Uloric) could escalate heart-related and all-cause mortality.

Study finds high unmet need among patients with uncontrolled gout.

The FDA has approved a new fixed-dose combination treatment for hyperuricemia in patients with uncontrolled gout.

Duzallo (lesinurad and allopurinol) may result in better disease control among patients with gout.

Lesinurad plus febuxostat provides dual mechanisms of action to lower urate levels for patients with tophaceous gout.

This article highlights 5 published case reports that document unusual drug overdoses.

Professional sample bottles of ticagrelor (Brilinta) may also contain a gout treatment.

Probenecid was found to reduce the symptoms of opioid misuse disorder.

The pharmacoeconomic impact of treating acute gout flares with ColciGel or with oralcolchicine.

Although the consumption of a number of foods is thought to trigger painful gout flair-ups, the results of a recent study have substantiated the belief that tomatoes are one of these foods.

Global gout treatment guidelines tend to differ on which drug should be used as first-line therapy for gout flares.

The disease of kings" can be a royal pain.

Drug therapy must balance the potential to improve quality of life with the risk of adverse effects. In the context of ever-increasing treatment complexity, striking this balance is getting complicated.

Can urate-lowering therapy for gout also reduce cardiovascular risk and mortality?

Did you know that gout has been recognized as a disease since 2640 BC?

ColciGel is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems.

A leader of a pharmacist-managed gout clinic has some insight that can help pharmacists improve the management of their patients' gout.

What gout risk factors should pharmacists be informing their patients about?

Research has shown that losing weight and increasing water intake can help reduce gout symptoms. However, there is another way patients with gout can reduce their symptoms: avoiding certain types of foods and drinks that can trigger flares.

Patients with sleep apnea have an increased risk of developing gout and nighttime flare-ups.

Some patients have shared that eating tomatoes caused them to experience gout flares, but these anecdotal claims have not been substantiated by medical literature.

Gout patients may be at greater risk for atrial fibrillation.

Researchers seek to improve treatment for autoimmune diseases, including rheumatoid arthritis, gout, Crohn's disease, and lupus.

Research ongoing to target treatment-resistant gout.

Patients with autoimmune conditions have an increased risk of developing shingles due to immune-suppressing treatment regimens.

Knowing these 10 facts can help manage patients with gout.